BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9922050)

  • 1. In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.
    Nüssler V; Pelka-Fleisc R; Gieseler F; Hasmann M; Löser R; Gullis E; Stötzer O; Zwierzina H; Wilmanns W
    Leuk Lymphoma; 1998 Nov; 31(5-6):589-97. PubMed ID: 9922050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
    den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ
    Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR; Kelsey SM; Wu YL; Newland AC
    Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of progesterone and leukotriene receptor antagonists in experimental models of P-glycoprotein-related resistance.
    Nuessler V; Pelka-Fleischer R; Zwierzina H; Wilmanns W; Denzlinger C
    Eur J Med Res; 1997 Apr; 2(4):159-64. PubMed ID: 9110922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study.
    Ivy SP; Olshefski RS; Taylor BJ; Patel KM; Reaman GH
    Blood; 1996 Jul; 88(1):309-18. PubMed ID: 8704189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Using protein chips to study mechanism underlying reversion of drug resistance in leukemia cells in tetrandrine alone or in combination with droloxifene].
    Chen BA; Du J; Zhang CX; Cheng J; Gao F; Lu ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):999-1003. PubMed ID: 16403267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
    Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.
    Davey MW; Hargrave RM; Davey RA
    Leuk Res; 1996 Aug; 20(8):657-64. PubMed ID: 8913319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
    Jachez B; Loor F
    Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
    Hill BT; Hosking LK
    Cancer Chemother Pharmacol; 1994; 33(4):317-24. PubMed ID: 8281626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
    Lehne G; Rugstad HE
    Br J Cancer; 1998 Sep; 78(5):593-600. PubMed ID: 9744497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
    Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
    Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
    Hofmann J; Utz I; Spitaler M; Hofer S; Rybczynska M; Beck WT; Herrmann DB; Grunicke H
    Br J Cancer; 1997; 76(7):862-9. PubMed ID: 9328144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T
    Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
    Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
    Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel bioassay for P-glycoprotein functionality using cytochalasin D.
    Elbling L; Berger W; Weiss RM; Printz D; Fritsch G; Micksche M
    Cytometry; 1998 Mar; 31(3):187-98. PubMed ID: 9515718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioassay for the activity of PSC 833 in human serum for modulation of P-glycoprotein-mediated multidrug resistance.
    Uchiyama-Kokubu N; Watanabe T; Nakajima M
    Anticancer Drugs; 2000 Aug; 11(7):583-90. PubMed ID: 11036963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.